Weekly CEO Buys: Ryman Hospitality, OPKO Health, Actuant Corp.
- By Joy Hu
According to GuruFocus Insider Data, these are the largest CEO buys during the past week. The overall trend of purchases is illustrated in the chart below:
Warning! GuruFocus has detected 7 Warning Signs with RHP. Click here to check it out.
The intrinsic value of RHP
Ryman Hospitality Properties Inc.: Chairman and CEO Colin V. Reed bought 7,377 shares
Reed bought 7,377 shares on July 15, 2016 at a price of $53.44.
Ryman Hospitality operates as real estate investment trust specializing in group-oriented, destination hotel assets in urban and resort markets. Ryman Hospitality has a market cap of $2.71 billion; as of July 15, its shares traded at $53.78 with a P/E ratio of 20.84.
The price of the stock has increased by 0.64% since Reed bought the stock.
OPKO Health Inc.: CEO, Chairman and 10% owner Phillip Frost bought 25,800 shares
Frost bought 25,800 shares during the past week at a price of $9.72.
OPKO Health was originally incorporated in Delaware in October 1991 under the name Cytoclonal Pharmaceutics Inc. The company is a multi-national biopharmaceutical and diagnostics company. OPKO Health has a market cap of $5.45 billion; as of July 15, its shares were traded at $9.95 with a P/E ratio of 68.15.
Consolidated revenues for the first fiscal quarter ended March 31 increased to $291.0 million from $30.1 million in the year-ago quarter. Net loss for the first quarter was $12.0 million compared with net loss of $117.1 milion for the 2015 period.
Frost bought 21,000 shares of OPK stock on June 27 at a price of $8.88 per share and 12,800 shares on June 29 at a price of $9.24 per share. The price of the stock has increased by 3.11% since.
Actuant Corp.: President and CEO Randal W. Baker bought 10,795 shares
Baker bought 10,795 shares on July 11 at a price of $23.14.
Actuant was incorporated in 1910 as a Wisconsin corporation. It is a diversified company that designs, manufactures and distributes various industrial products and systems. Actuant has a market cap of $1.42 billion; as of July 15, its shares traded at $24.08.
Consolidated sales for the third quarter were $305 million, 5% lower than the $320 million in the comparable prior year quarter. Fiscal 2016 third quarter net earnings were $21.2 million, or 36 cents per share compared to $38.0 million or 63 cents per share in the comparable prior year period.
The price of the stock has increased by 4.06% since Baker bought the stock.
For the complete list of stocks that were bought by their company CEOs, go to: CEO Buys.
This article first appeared on GuruFocus.
Warning! GuruFocus has detected 7 Warning Signs with RHP. Click here to check it out.
The intrinsic value of RHP